Figure 1. Cell-free Reconstitution of ARFDependent Protein Recruitment to Synaptic Vesicles
Size-purified synaptic vesicles from rat brain (right) or from 125 I-KT3 endocytically labeled PC12N49A cells (left) were incubated with either 30 M Q71L ARF1 (open circles, triangles, and squares) or T31N ARF1 mutant (closed circles). Reaction mixtures were reconstituted without cytosol (A and B) or in the presence of 3 mg/ml rat brain cytosol (C-H, circles). In (G) and (H), brain cytosol was replaced by either liver cytosol (triangles) or yeast cytosol (squares). Mixtures were kept at 37ЊC for 30 min, except for (E) and (F) where incubation was at 0ЊC. Reactions were stopped at 0ЊC, and vesicles were resolved in 10%-45% continuous sucrose gradients. Synaptic vesicles migrated faster on sucrose gradients (C and D, open circles) only in the presence of rat brain cytosol and Q71L ARF1 mutant. Synaptophysin in rat brain SV fractions was detected with a specific antibody in an ELISA assay; radioactivity in SVs from PC12 cells was counted in a gamma counter.
coats involved in the PC12 endosome-derived SV bud-1.11). The recruitment of coats to SVs was sensitive to temperature. At 4ЊC , or at 15ЊC (data not shown), addiding, purified SVs were coated in an ARF1-dependent "backward" coating reaction in which GTP hydrolysis tion of the Q71L mutant in the presence of brain cytosol did not modify SV migration (Figures 1E and 1F) . Incubawas inhibited.
Synaptic vesicles from either rat brain or from endotion of unlabeled brain SVs with labeled PC12 SVs decreased the Q71L-dependent shift of the labeled SVs cytically labeled PC12 cells were purified by velocity sedimentation and then incubated with rat brain cytosol, (data not shown). Thus, rat brain SVs are competing for the same cytosolic factor(s) required for coating the an ATP-regenerating system, and myristoylated ARF1 mutants, either the GTP form (Q71L) or the GDP counter-PC12 SVs. ARF-dependent recruitment of coats to SVs was depart (T31N). ARF-regulated recruitment of cytosolic proteins to SVs increased the rate of vesicle sedimentation pendent on the source of the cytosol. At equal protein concentrations, neither rat liver nor yeast-derived cytointo nonequilibrium sucrose gradients. Without coat recruitment, purified rat brain and PC12 SVs were recovsol substituted for brain cytosol, implying that a neuronspecific protein is recruited to the membranes (Figures ered at 25%-26% and 22%-24% sucrose, respectively. The sedimentation of both kinds of SVs was unaltered 1G and 1H). Coat recruitment also required the addition of a hydrolyzable form of ATP (data not shown). by the addition of either rat brain cytosol or the ARF1 mutants alone (Figures 1A and 1B) . In the presence of both Q71L ARF1 and rat brain cytosol at 37ЊC, synaptic vesicles sediment to greater sucrose concentrations GTP-ARF1 Mutant-Dependent Protein Recruitment Is a Saturable Process that Requires than controls (32%-34% sucrose for PC12 SVs and 29%-30% sucrose for rat brain SVs) (Figures 1C and
SV-Associated Proteins
Recruitment of cytosolic factors to SV is saturable. The 1D). The GDP-form of ARF1 (T31N) did not increase the sedimentation rate, consistent with a GTP-ARF-depenincrease in sedimentation rate induced by cytosol and the GTP-ARF1 mutant reached a plateau at 3 mg/ml dent recruitment of protein to membranes (Faú ndez et al., 1997) . When centrifuged for enough time to reach and 30 M, respectively. Saturation of the density shift occurred at 20 M GTP␥S. Samples were preincubated equilibrium density, the coated PC12 vesicles migrated as a single sharp peak at 39.7% Ϯ 1.3% sucrose (n ϭ 4) at 37ЊC with the dominant negative T31N mutant of ARF1 before the addition of GTP␥S. The GDP-bound mutant ( ϭ 1.17), whereas T31N-treated SVs equilibrated at 27.5% Ϯ 0.5% sucrose (n ϭ 2), similar to untreated SVs, showed competitive inhibition, indicating that a limited number of saturable ARF-binding sites are required for which are recovered 27% Ϯ 0.5% sucrose (n ϭ 2) (r ϭ kDa ( Figure 3A , compare lanes 3 and 4). Recruitment of these proteins to the beads required that SVs were attached ( Figure 3A , compare lanes 2 and 4). The GTPbound form of ARF recruited the same proteins to the vesicles whether it was the Q71L ARF mutant or wildtype ARF bound to nonhydrolyzable GTP␥S ( Figure 3A , compare lanes 4 and 8). The bands of about 21 kDa found in the absence of SVs ( Figure 3A , lane 6) corresponded to nonspecific binding of the mutant ARF to the matrix (data not shown).
The identity of the 150 kDa band was addressed by immunoblot. Two different antibodies against the hydro- Figure 3B , lane 4; Figure 3C , lanes 4 and 8; data not 0ЊC with 25 g/ml pronase either active or preinactivated with PMSF.
shown) whether the coat was recruited by GTP␥S or by Proteolysis was stopped with 4 mM PMSF at 0ЊC and SVs were the addition of the Q71L GTP-ARF1 mutant ( Figure 3C , isolated in velocity glycerol gradients. Pronase-treated (squares) or lanes 4 and 8, respectively). In agreement with the promock-digested (circles) vesicles were reconstituted with 3 mg/ml tein stain ( Figure 3A ), no ␤3 subunit recruitment was rat brain cytosol in the presence of either 30 M Q71L ARF1 mutant (open symbols) or T31N ARF1 mutant (closed symbols). Reactions detected in the absence of vesicles ( Figure 3B , lane 2;
were stopped and vesicle sedimentation was analyzed as previously Figure 3C , lanes 2 and 6) or the activated ARF protein described. Proteolyzed vesicles did not shift to 33% sucrose on ( Figure 3B , lane 3; Figure 3C , lanes 3 and 7). Other sucrose gradients after addition of brain cytosol and Q71L ARF1.
subunits of the AP3 coat complex were recruited concomitantly with the ␤3 subunit. The bands around 21 the coating, and that the GTP␥S effect is likely to involve kDa were identified as the subunits A and B of the 3 ARF (data not shown).
protein ( Figure 3B , lane 12; 3C, lanes 4 and 8), and also, Since coat and ARF1 can be recruited to protein-free ARF proteins recruited to the vesicles ( Figure 3B , lane lipid interfaces (Franco et al., 1993; 16) . In addition, although it was not clearly distinguish- Ktistakis et al., 1996) , we asked if the SV protein recruitable by total protein staining, 3/p47 was also recruited ment was due to a lipid binding process or to cytoto the vesicles, in parallel with the other subunits of the plasmic domains of proteins. Controlled protease dicomplex ( Figure 3B , lane 8 ). gestions were performed using endocytically labeled, The AP3 complex was also recruited to rat brain-PC12-derived synaptic vesicles. Under the conditions derived SVs in the presence of GTP␥S. Rat brain synaptested, the protease treatment did not change the SV tic vesicles were incubated in the presence of cytosol migration on glycerol velocity gradients nor reduce the either in the absence or presence of 20 M GTP␥S and luminal content of labeled anti-TAg antibody (data not analyzed on sucrose gradients. After the addition of shown). Control reactions were identical except that GTP␥S, the vesicles were shifted from 24% to 29% suprotease inhibitors were added to pronase prior to the crose ( Figures 4A and 4B ). Concomitantly, ARF (Figures addition of membranes. Vesicles treated with pronase 4G and 4H), and the AP3 subunits, ␤3 and 3, became lost their ability to migrate faster in the presence of the associated with the vesicles ( Figures 4C and 4D , and Q71L ARF1 mutant and rat brain cytosol (Figure 2, open 4E and 4F, respectively) . These results show that the squares). Controls where pronase incubation was in the AP3 complex binds to SVs in an ARF-dependent way presence of protease inhibitors showed the normal regardless of the source of synaptic vesicles. change in sedimentation rate (Figure 2 , open circles).
To determine whether AP3 was exclusively recruited No shift was observed when T31N ARF was used, with to SVs, we assayed for other coats whose binding to or without pronase activity (Figure 2 , closed symbols).
membranes is regulated by small GTP-binding proThese results show that the GTP-ARF1-triggered proteins ( Figure 5 ). Neither AP1, assessed by antibodies to tein recruitment to SV is a saturable process that re-␥-adaptin, nor COPI, assessed by antibodies to ␤-and quires protein acceptor site(s) on the vesicles.
⑀-COP (data not shown), nor COPII, assessed by antibodies to mSec13p, was recruited to PC12 SVs after AP3 Coat Complex Recruitment to Synaptic the addition of GTP␥S. Similarly, neither clathrin nor Vesicles Is ARF-Dependent AP180 was detected on PC12 SVs after the addition of In order to identify the putative coat, we performed pro-GTP␥S. However, ␣-adaptin and dynamin were recruited tein recruitment reactions using a PC12 SV affinity to membranes in the presence of nucleotides. These column. Synaptic vesicles were immunoimmobilized to interactions with SVs were not detected by protein stain protein G-Sepharose beads that were coated with anti-( Figure 3A ), suggesting a relatively low abundance of body (SY38) to the synaptophysin cytosolic domain. these proteins. These antibodies did not inhibit the change in sedimenWeak interaction of AP2 with rat brain SVs was obtation rate on sucrose gradients (data not shown). After served. Coat complexes recruited to rat brain SVs by incubating the immobilized vesicles in the presence of GTP␥S were analyzed by sucrose gradient centrifugarat brain cytosol and GTP␥S at 37ЊC, two prominent tion. The nucleotides induced a detectable increase in bands became associated with the vesicles, one of apthe amount of ␣-adaptin in the position of the shifted SVs ( Figures 4I and 4J ). These results show that the AP3 proximately 150 kDa and the other migrating around 21 complex is preferentially recruited into SVs, but that required. The AP3 coat complex from bovine brain cytosol could be enriched approximately 60-fold and sepasome AP2 recruitment may also be occurring.
rated from AP2 by a combination of ammonium sulfate precipitation, DEAE Sepharose, Superose 6, and Mono The AP3 Complex Is Required for SV Budding from PC12 Endosomes Q chromatography ( Figure 6A ). The AP3-containing fractions were essentially devoid of the AP2 complex and We used the cell-free SV budding assay (Desnos et al., 1995) to examine which adaptor complexes were ARF1 by Western blot (data not shown). When labeled bands ( Figure 6E ) that were shown to be the ␦, ␤3, 3, 3A, and 3B subunits by immunoblotting with specific antibodies. To examine cytosol dependence, PC12 membranes were washed free of cytosol through a Percoll gradient then incubated under standard assay conditions using a concentration of brain cytosol that gave a maximum response. Replacing cytosol with pure AP3 and recombinant ARF1 allowed SV budding to an extent even greater than that achieved with saturating levels of brain cytosol. Neither AP3 nor ARF1 alone reconstituted the budding activity (9% Ϯ 7% and 33% Ϯ 3%, respectively). Thus, the AP3 coat complex and ARF1 are sufficient for the formation of SVs from endosomal donors.
Discussion
Coated intermediates involved in membrane traffic have been identified by forming them from donor compartments and preventing their uncoating. Here we describe the formation of a coated intermediate by a reverse reaction, incubating purified carrier vesicles, in this case synaptic vesicles, under conditions that favor their coating. AP3 and ARF1 were shown to be recruited to both , 1995) . ATP and temperature-dependent synaptic vesicle coat-PC12 donor membranes were incubated with ARF1-, ing were not reported in earlier studies (Zhang et al., ATP-, and AP3-containing fractions, SV budding was 1994). One possibility is that the recently described AP3 observed ( Figure 6B ). In a second set of experiments, coats self-assemble much more readily than the other rat brain cytosol was immunodepleted using polyclonal more fully described adaptors. It is also possible that anti-3 antibodies that recognize the whole AP3 comearlier studies were more biased toward spontaneous plex in its native state (Dell'Angelica et al., 1997a) . These binding reactions occurring at 4ЊC. The coating reaction antibodies removed more than 95% of the 3 subunits described here requires temperatures above 15ЊC, and from brain cytosol ( Figure 6C , insert). Cell-free SV forma-ATP, suggesting an enzymatically driven or regulated tion was analyzed using 3-depleted cytosol and donor assembly. membranes from cells labeled either at 15ЊC or in the The assay we utilize measures budding from the endopresence of BFA (5 g/ml) ( Figure 6D ). Results were some. It cannot detect vesicle budding from biosynnormalized against control reactions performed with thetic compartments such as endoplasmic reticulum or mock-depleted rat brain cytosol. Both donor membranes Golgi membranes since the synaptic vesicles were ladecreased their capacity to bud SVs by 42% Ϯ 7% (n ϭ beled via antibody endocytosis. The precursor is not the 7) from 15ЊC-labeled donor membranes and 39% Ϯ 4% plasma membrane since more than 95% of the plasma (n ϭ 5) from the BFA-labeled ones ( Figure 6B ). The effect membrane can be removed from the donor membranes of depleting the 3 subunit was abrogated by adding without eliminating the budding activity (Y. Lichtenstein, back the Mono Q AP3-containing fractions (n ϭ 4) (Fig-C . Desnos, V. F., L. Clift-O'Grady, and R. B. K., unpubure 6D), showing that the 3 depletion effect upon vesilished data). Furthermore, it is known both by light and cle formation was reversible and linked to the removal electron microscopy that AP3 can be bound to endoof AP3 complex.
somes (Dell'Angelica et al., 1997a , 1998 . Endosomes These indications that AP3 was involved in coating in PC12 cells that are labeled by internalizing markers and budding motivated us to determine if AP3 and ARF1 at 15ЊC can also be shown to have AP3 coats by immuwere the only cytosolic requirements for budding to noelectron microscopy (J. Klumperman, personal compurify the AP3 to homogeneity. The budding activity munication). If AP3 is mediating vesicle budding from continued to coelute with AP3 after additional chroma-PC12 endosomes, then two issues arise. How can we tography steps on hydroxyapatite and Mono S columns.
relate these observations to the data that AP2 and At this point, the preparation had a specific activity in clathrin are involved in SV formation and to the more the budding assay that was about 500-fold higher than recent evidence implicating AP3 in biosynthetic rather the starting material. Analysis of the preparation by SDS-PAGE revealed that the preparation contained only five than endocytotic pathways?
Considerable evidence indicates that synaptic vesicles can be formed by a pathway that involves AP2, clathrin, and dynamin (van de Goor et al., 1995; Koenig and Ikeda, 1996; Takei et al., 1996; Cremona and De Camilli, 1997 ; Gonzá lez-Gaitá n and Jä ckle, 1997; Shupliakov et al., 1997) . Elegant electron microscopic studies have shown that steps mediated by clathrin and dynamin appear to occur at the plasma membrane although some budding may take place from internalized membranes (Takei et al., 1996) . One plausible explanation is that nerve terminals use two modes of vesicle formation, one that generates synaptic vesicles from the plasma membrane using clathrin and dynamin and a second that uses AP3 and ARF1 to generate synaptic vesicles from endosomes. Direct experimental support for two pathways of biogenesis has recently been obtained in PC12 cells. In addition to the AP3-requiring, clathrin-independent pathway from the endosomes described here, PC12 cells have a second pathway that is AP3 independent but requires AP2 and clathrin (G. Shi, V. F., J. Roos, and R. B. K., unpublished data). One possible function for the AP3 pathway in neurons is the generation of synaptic vesicles from the extensive invaginations that form in nerve terminals after intense stimulation (Heuser and Reese, 1973) .
It is also necessary to reconcile AP3-mediated budding from endosomes with recent data from yeast, Drosophila, and mice that implicate AP3 in a biosynthetic pathway to lysosomes and a subclass of storage vesicles. Deletion of AP3 subunits inhibits the delivery of newly synthesized alkaline phosphatase and a t-SNARE, Vam3p, to the yeast vacuole (Cowles et al., 1997; Stepp et al., 1997) , which implies that AP3 may facilitate bud- considered as modified lysosomes, AP3 would again A and B represent pooled fractions from the Mono Q column that appear to be involved in a specialized Golgi-to-lysoeluted before and after the AP3-containing peak. somal pathway, in this case to a pigment storage vesicle. performed at 37ЊC for 30 min in the presence of either 1.5 mg/ml (D) Combined data from in vitro budding experiments from PC12N49A of bovine brain cytosol (BBC, n ϭ 3), 8.5 g/ml of purified bovine membranes labeled either at 15ЊC or 37ЊC in the presence of 5 g/ brain AP3 coat complex (AP3, n ϭ 2), 40 M recombinant wild-type ml brefeldin A (BFA) to prevent SV formation in vivo (Faú ndez et al., ARF1 (ARF1, n ϭ 2), or the combined addition of ARF1 and AP3 1997). 3 depletion substantially reduces the SV budding activity complex (40 M and 8.5 g/ml, respectively; AP3/ARF1, n ϭ 3). In of both properties of donor membranes. The final column (Mono Q) vitro budding reactions performed in the presence of pure AP3 describes experiments in which the Mono Q AP3-enriched fractions coat complex or ARF1 alone generated small amounts of vesicles were added back to the 3-depleted cytosol, and the budding was whereas both components together were synergistic in vesicle genperformed from membranes labeled at 15ЊC. The SV budding eration. The genetic data from the pigment dilution mice imply that AP3 has an important but not essential pathway in [pH 7.2], 5 mM reduced glutathione, 5 mM sodium carbonate, 2.5 mM magnesium sulfate), spun at 218,000 ϫ g for 75 min in an SW55 rotor (Beckman Instruments, Palo Alto, CA). The SV peak, Experimental Procedures determined either by immunoblot or an ELISA-based assay using the SY38 antibody (Wagner et al., 1978) , was pooled and flash frozen Reagents in liquid nitrogen and stored at Ϫ80ЊC until use. Similar results were [ 125 I]Na and ECL reagents were obtained from Amersham Corp (Arobtained using frozen or freshly prepared vesicles. lington Heights, IL). All the nucleotides, creatine phosphate, creatine PC12 SVs were isolated from the PC12/N49A cell line transfected kinase, and Sephadex G25 were purchased from Boehringer Mannwith an epitope-tagged version of the synaptic vesicle protein heim Corp (Indianapolis, IN). DEAE Sepharose, Protein G-Sepharose VAMP2, mutant N49A (Grote et al., 1995) . Cells were labeled at 15ЊC 4 Fast Flow, Superose 6, and the Mono Q and Mono S FPLC columns with iodinated anti-TAg antibodies washed and homogenized as were obtained from Pharmacia Biotech (Uppsala, Sweden). Brefeldescribed (Desnos et al., 1995; Faú ndez et al., 1997) . Labeled SVs din A was purchased from Epicenter Technologies (Madison, WI).
were isolated on glycerol velocity gradients as described for rat Cell culture media and reagents were obtained from the University brain vesicles. of California Cell Culture Facility (San Francisco, CA). Geniticin
The synaptic vesicle content was determined semiquantitatively (G418) and IPTG were obtained from GIBCO BRL (Gaithersburg, by immunoblot, using the monoclonal antibody 69.1 anti-VAMP2 MD). Percoll and all the other reagent grade chemicals were purand GST-VAMP2 as standard. Several dilutions of GST-VAMP stanchased from either Sigma (St. Louis, MO), Fisher Chemical (Fairlawn, dard (115 ng to 1.15 g) were resolved in 15% PAGE-SDS gels NJ), or Calbiochem (San Diego, CA). Female Sprague-Dawley rats together with several dilutions of SVs and immunoblotted with the were from Bantin and Kingman (Fremont, CA).
69.1 monoclonal antibody. The immune complexes were detected by ECL. The SV content was determined after quantitating different Cell Culture time exposures with the NIH Image 1.60 program (Faú ndez et al., The PC12 cell line stably transfected with the mutant VAMP N49A 1997). was grown and induced with 6 mM sodium butyrate as described (Grote et al., 1995) .
Cytosol Preparations
Either rat or bovine brain cytosol and rat liver cytosol were prepared as described (Desnos et al., 1995) . Saccharomyces cerevisiae cytoAntibodies sol (strain CTY182 Mat␣, ura 3-52, his 3-200, lys 2-801) was obMonoclonal antibodies against synaptophysin (SY38) were purtained as described (Baker et al., 1988 ) (a gift of Dr. A. E. Cleves, chased from Boehringer Mannheim (Indianapolis, IN). Polyclonal MetaXen, Hayward, CA). antibodies against ␤-NAP 647-796 that recognize ␤3A and ␤3B, against delta, against 3/p47, and against 3 were a generous gift of Drs. E. Dell'Angelica and J. Bonifacino (NIH, Bethesda, MD) (Ooi et al.,
SV Coating Assay
Cell-free synaptic vesicle coating assays were performed in 250 l 1997; Dell'Angelica et al., 1997a) . The polyclonal antibody Nb directed against ␤-NAP was a gift of Dr. R. Darnell (Rockefeller Univertotal volume in intracellular buffer, using PC12/N49A 125 I-KT3 labeled vesicles, 100-500 ng of VAMP2 content per assay or rat brain synapsity, NY) (Newman et al., 1995) . Anti-ARF antibodies used in this study were either polyclonal antibodies raised in rabbits immunized tic vesicles, 300-1400 ng of VAMP2 content per assay; and in the absence or presence of rat brain cytosol, ATP regenerating system with myristoylated recombinant human mutant ARF1 Q71L or the monoclonal antibody 1D9 (Cavenagh et al., 1996) (a generous gift and either T31N ARF1 or Q71L ARF1 mutants or GTP␥S. Reconstituted mixtures were kept at 4ЊC for 15 min. Coating reactions were of Dr. R. Kahn, Emory University, Atlanta, GA). Polyclonal antibodies started by warming to 37ЊC. Reactions were stopped at 4ЊC for 10 over homogenate levels. AP3 was further purified from Mono Q fractions by subsequent hydroxyapatite and Mono S chromatogramin and loaded on the top of continuous 10%-45% sucrose gradients buffered in 20 mM MOPS-KOH (pH 7.4), 0.5 mM MgCl2. Sucrose phy. AP3-containing fractions from the Mono Q column were supplemented with phosphate buffer to a final concentration of 150 mM gradients were centrifuged at 183,000 ϫ g for 150 min in an SW55 rotor. were collected from the bottom of the gradiand loaded onto a hydroxyapatite column (CHT5-I, Bio-Rad). Proteins were eluted with 150-550 mM potassium phosphate buffer ent and either counted in a gamma counter or resolved in PAGE-SDS gels and immunoblotted with different antibodies.
(containing 5 mM MgCl2, 1 mM DTT, and 10% glycerol). AP3-containing fractions were dialyzed against buffer C (25 mM MES-KOH [pH 6.0], 5 mM MgCl 2, 1 mM DTT, and 10% glycerol). The sample Protease Treatment was absorbed to a Mono S column (Pharmacia, Uppsala, Sweden) Homogenates containing 125 I-KT3 labeled SVs were prepared as equilibrated with buffer C. The column was washed with buffer C before except that protease inhibitors were omitted from the buffer.
and subsequently eluted with 0-500 mM NaCl in buffer C. The AP3-A postnuclear supernatant (S1; 1000 ϫ g for 5 min) was sedimented containing fractions were pooled and dialyzed in intracellular buffer. at 27,000 ϫ g for 35 min, and the supernatant generated (S2) was
Immunodepletions were performed with preimmune or anti-3 used for controlled proteolysis. S2s (1 mg) were treated with 25 antibodies prebound to protein G-Sepharose essentially as deg/ml of pronase either inhibited or not with 4 mM PMSF. Digestions scribed (Faú ndez et al., 1997) were performed for 30 min at 0ЊC, and reactions were stopped by the addition of 4 mM PMSF. Mock digested and digested S2 were loaded onto 5%-25% glycerol gradients prepared in intracellular Cell-Free SV Biogenesis Assay buffer over a 50% sucrose cushion, then spun at 218,000 ϫ g for PC12 N49A cells were labeled at 15ЊC with iodinated anti-TAg anti-75 min in an SW55 rotor (Beckman Instruments, Palo Alto, CA).
bodies as described (Desnos et al., 1995; Faú ndez et al., 1997) . Fractions (17-18) were collected from the bottom. The SV peak from After washing the unbound 125 I-KT3 antibody, cells were homogeboth conditions was identified by counting. No differences in the nized either immediately or after an incubation at 37ЊC for 15 min sedimentation properties and intravesicular 125 I-KT3 content were in the presence of 5 g/ml brefeldin A in media DME-H21 suppledetected under these conditions. Complete proteolysis was conmented with 10 mM HEPES at pH 7.4. To remove endogenous PC12 firmed by blotting vesicles with antibodies to synaptophysin and cytosol, cell homogenates were loaded on the top of a discontinuous VAMP2. SVs were used immediately for coating reactions as already gradient of 3 ml 50% Percoll and 9 ml 10% Percoll prepared in described. intracellular buffer. Samples were sedimented at 27,000 ϫ g for 45 min in an SS34 rotor. Membranes were recovered from the Percoll interface to be used in the cell-free assays.
SV Affinity Chromatography
Percoll-washed membranes (250-500 g per assay) prepared Antibodies against the cytosolic tail of synaptophysin (SY38, 2.5 g) from either 15ЊC or brefeldin A-treated cells were reconstituted in were bound to 25 l of protein G Sepharose. SVs were bound to the presence of an ATP regenerating system (1 mM ATP, 8 mM the matrix for 3 hr at 4ЊC, and the unbound vesicles were washed creatine phosphate, 5 g/ml creatine kinase) either with 2.5 mg/ml away in intracellular buffer supplemented with 0.1% ovalbumin. Reof cytosol either mock-depleted or depleted with antibodies against action mixtures containing 3 mg/ml rat brain cytosol, in the absence 3, or Mono Q fractions supplemented with 30 M wild-type ARF1. or presence of either 50 M Q71L ARF1 mutant or 20 M GTP␥S, Reactions were kept at 4ЊC for 15 min to be initiated at 37ЊC for 30 were incubated for 15 min at 4ЊC followed by warming to 37ЊC for min. The vesicle budding was stopped at 4ЊC. All the fractionation 40 min with periodic resuspension of the beads. After arresting the procedures, glycerol velocity gradients, and vesicle budding activity reactions at 4ЊC, the matrix was washed in intracellular buffer, and quantitations were performed following the procedures described the retained proteins were eluted with Laemmli sample buffer and in Faú ndez et al. (1997) . resolved in 8%-18% gradient PAGE-SDS gels prior to immunoblotting.
Other Procedures Cytosol Fractionation and Immunodepletion
KT3 monoclonal antibodies were iodinated by chloramine-T (Faú nSize fractionation of the rat brain cytosol in a Superose 6 column dez et al., 1992). Protein assays were performed using the Bio-Rad was performed as previously described (Faú ndez et al., 1997) .
Protein Assay Dye Reagent (Bio-Rad, Richmond, CA) using BSA as To obtain fractions enriched in AP3 complex, liquid nitrogen flashstandard. Gel protein staining was performed using the fluorescent frozen bovine brains (Pel-Freeze, Biologicals, Rogas, AR) were dye SYPRO Orange (Bio-Rad, Richmond, CA) following the manuthawed then homogenized using a Waring blender at a ratio 1:2 facturer's instructions. (w:v) in buffer A (25 mM Tris-HCl [pH 8.0]; 500 mM KCl, 2 mM EGTA, 1 mM DTT in the presence of a proteinase inhibitory mix). Acknowledgments Homogenates were sedimented at 10,400 ϫ g for 1 hr in a GSA rotor, and supernatants were dialyzed for 2 hr against 6 liters of We wish to thank Drs. Darnell, Rothman, Kahn, Bonifacino, Brodsky, buffer B (25 mM Tris-HCl [pH 8.0]; 5 mM MgCl 2 , 1 mM DTT) and Kaiser, Jahn, and Shields for gifts of antibodies or DNA. Comments then overnight in 6 liters of the same buffer. After sedimenting the on the manuscript by Drs. Brodsky, Mostov, and Herman were much dialyzed material at 11,750 ϫ g for 1 hr in a GSA rotor, the supernaappreciated. The research was supported by NIH grants (NS09878, tants were salted out by 35% (NH4)2SO4. Precipitated proteins were NS15927, and DA10154), by an NIH Fogarty Fellowship to Dr. Faú nrecovered by spinning at 10,400 ϫ g for 20 min. Pellets were resusdez, and an equipment grant from the Academic Senate, UCSF. pended in buffer B and applied to a DEAE-Sepharose CL-6B column preequilibrated with buffer B containing 100 mM NaCl and 10%
Received December 8, 1997; revised March 25, 1998. glycerol (v:v) . Unbound proteins were washed out with equilibrium buffer. Bound proteins were eluted by a linear gradient of 100-600 References mM NaCl in buffer B. ␤-NAP and 3 were detected by immunoblot, and the fractions containing both of them were pooled and applied Aniento, F., Gu, F., Parton, R.G., and Gruenberg, J. (1996) . An endoto a Superose 6 column preequilibrated in intracellular buffer. Peak somal ␤ COP is involved in the pH-dependent formation of transport fractions containing both ␤-NAP and 3 were directly applied to a vesicles destined for late endosomes. J. Cell Biol. 133, 29-41. Mono Q 5-5 column preequilibrated in 150 mM NaCl in buffer B and Baker, D., Hicke, L., Rexach, M., Schleyer, M., and Schekman, R. eluted by a linear gradient of 100-600 mM NaCl in buffer B. The (1988) . Reconstitution of SEC gene product-dependent intercomMono Q peak containing both ␤-NAP and 3, and the fractions partmental protein transport. Cell 54, 335-344. upstream (A) or downstream (B) of it were pooled, concentrated, and extensively dialyzed against intracellular buffer before being Baumert, M., Maycox, P.R., Navone, F., De Camilli, P., and Jahn, R. (1989). Synaptobrevin: an integral membrane protein of 18,000 used in the cell-free synaptic vesicle assay. The AP3 complex eluted from the Mono Q column at 320 mM NaCl. These fractions were daltons present in small synaptic vesicles of rat brain. EMBO J. 8, 379-384. devoid of AP2. This procedure enriched the AP3 complex 60 times
